$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Total Non-Current Liabilities
$1.17B
Quarterly · Period ending: · USD

RARE Total Non-Current Liabilities
Latest reported$1.22Bperiod ending
Latest reported$1.22Bperiod ending
RARE FY Total Non-Current Liabilities ($487.00K → $1.22B)
Annual total non-current liabilities
High-resolution chart · PNG
What is total non-current liabilities?
Long-term obligations due beyond one year.
RARE total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 1,221,000,000 | |
| 897,006,000 | |
| 935,162,000 | |
| 931,740,000 | |
| 418,468,000 | |
| 415,571,000 | |
| 378,432,000 | |
| 35,925,000 | |
| 36,285,000 | |
| 6,393,000 | |
| 561,000 | |
| 505,000 | |
| 3,619,000 | |
| 788,000 | |
| 487,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance